Skip to main content
Top
Published in: Journal of Gastrointestinal Surgery 2/2013

01-02-2013 | 2012 SSAT Quick Shot Presentation

Usefulness of Contrast-Enhanced Intraoperative Ultrasonography (CE-IOUS) in Patients with Colorectal Liver Metastases after Preoperative Chemotherapy

Authors: Andrea Ruzzenente, Simone Conci, Calogero Iacono, Alessandro Valdegamberi, Tommaso Campagnaro, Francesca Bertuzzo, Fabio Bagante, Michela De Angelis, Alfredo Guglielmi

Published in: Journal of Gastrointestinal Surgery | Issue 2/2013

Login to get access

Abstract

Aims

The aim of this study was to evaluate the ability of contrast-enhanced intraoperative ultrasonography to detect colorectal liver metastases after preoperative chemotherapy compared with intraoperative ultrasound and preoperative imaging techniques.

Methods

From January 2010 to December 2011, 28 patients with colorectal liver metastases underwent intraoperative ultrasonography and contrast-enhanced intraoperative ultrasonography during hepatectomy following preoperative chemotherapy. The findings were compared to preoperative imaging using contrast-enhanced ultrasonography, computed tomography, magnetic resonance imaging, and/or fluorodeoxyglucose positron emission tomography.

Results

Preoperative imaging techniques detected 58 metastatic lesions in 28 patients. In 32 % of patients (n = 9), intraoperative ultrasound detected 24 missed hepatic nodules. In 14 % of patients (n = 4), contrast-enhanced intraoperative ultrasonography detected an additional six nodules and change in operative management occurred in 18 % of patients. Using univariate analysis, we found three factors significantly related to detection of additional metastases with contrast-enhanced intraoperative ultrasonography: three or more metastases before chemotherapy (p = 0.047), resolution of at least one metastasis (p = 0.011), and small liver metastases (largest lesion size ≤20 mm) after chemotherapy (p = 0.007).

Conclusion

In patients undergoing surgery for colorectal liver metastases after chemotherapy, contrast-enhanced intraoperative ultrasonography improved both the sensitivity of intraoperative ultrasonography to detect liver metastases and the R0 hepatic resection rate.
Literature
1.
go back to reference O’Brien MJ: Cancer of the colon and rectum: Current concepts of aetiology and pathogenesis. Ir J Med Sci 1988;157:5–15.PubMedCrossRef O’Brien MJ: Cancer of the colon and rectum: Current concepts of aetiology and pathogenesis. Ir J Med Sci 1988;157:5–15.PubMedCrossRef
2.
go back to reference McArdle CS, Hole D, Hansell D, Blumgart LH, Wood CB: Prospective study of colorectal cancer in the west of scotland: 10-year follow-up. Br J Surg 1990;77:280–282.PubMedCrossRef McArdle CS, Hole D, Hansell D, Blumgart LH, Wood CB: Prospective study of colorectal cancer in the west of scotland: 10-year follow-up. Br J Surg 1990;77:280–282.PubMedCrossRef
3.
4.
go back to reference Simmonds PC, Primrose JN, Colquitt JL, Garden OJ, Poston GJ, Rees M: Surgical resection of hepatic metastases from colorectal cancer: A systematic review of published studies. Br J Cancer 2006;94:982–999.PubMedCrossRef Simmonds PC, Primrose JN, Colquitt JL, Garden OJ, Poston GJ, Rees M: Surgical resection of hepatic metastases from colorectal cancer: A systematic review of published studies. Br J Cancer 2006;94:982–999.PubMedCrossRef
5.
go back to reference Scheele J, Stang R, Altendorf-Hofmann A, Paul M: Resection of colorectal liver metastases. World J Surg 1995;19:59–71.PubMedCrossRef Scheele J, Stang R, Altendorf-Hofmann A, Paul M: Resection of colorectal liver metastases. World J Surg 1995;19:59–71.PubMedCrossRef
6.
go back to reference Fong Y, Fortner J, Sun RL, Brennan MF, Blumgart LH: Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: Analysis of 1001 consecutive cases. Ann Surg 1999;230:309–318; discussion 318–321.PubMedCrossRef Fong Y, Fortner J, Sun RL, Brennan MF, Blumgart LH: Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: Analysis of 1001 consecutive cases. Ann Surg 1999;230:309–318; discussion 318–321.PubMedCrossRef
7.
go back to reference Nordlinger B, Sorbye H, Glimelius B, Poston GJ, Schlag PM, Rougier P, Bechstein WO, Primrose JN, Walpole ET, Finch-Jones M, Jaeck D, Mirza D, Parks RW, Collette L, Praet M, Bethe U, Van Cutsem E, Scheithauer W, Gruenberger T: Perioperative chemotherapy with folfox4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (eortc intergroup trial 40983): A randomised controlled trial. Lancet 2008;371:1007–1016.PubMedCrossRef Nordlinger B, Sorbye H, Glimelius B, Poston GJ, Schlag PM, Rougier P, Bechstein WO, Primrose JN, Walpole ET, Finch-Jones M, Jaeck D, Mirza D, Parks RW, Collette L, Praet M, Bethe U, Van Cutsem E, Scheithauer W, Gruenberger T: Perioperative chemotherapy with folfox4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (eortc intergroup trial 40983): A randomised controlled trial. Lancet 2008;371:1007–1016.PubMedCrossRef
8.
go back to reference Folprecht G, Gruenberger T, Bechstein WO, Raab HR, Lordick F, Hartmann JT, Lang H, Frilling A, Stoehlmacher J, Weitz J, Konopke R, Stroszczynski C, Liersch T, Ockert D, Herrmann T, Goekkurt E, Parisi F, Kohne CH: Tumour response and secondary resectability of colorectal liver metastases following neoadjuvant chemotherapy with cetuximab: The celim randomised phase 2 trial. Lancet Oncol 2009;11:38–47.PubMedCrossRef Folprecht G, Gruenberger T, Bechstein WO, Raab HR, Lordick F, Hartmann JT, Lang H, Frilling A, Stoehlmacher J, Weitz J, Konopke R, Stroszczynski C, Liersch T, Ockert D, Herrmann T, Goekkurt E, Parisi F, Kohne CH: Tumour response and secondary resectability of colorectal liver metastases following neoadjuvant chemotherapy with cetuximab: The celim randomised phase 2 trial. Lancet Oncol 2009;11:38–47.PubMedCrossRef
9.
go back to reference Adam R, Bhangui P, Poston G, Mirza D, Nuzzo G, Barroso E, Ijzermans J, Hubert C, Ruers T, Capussotti L, Ouellet JF, Laurent C, Cugat E, Colombo PE, Milicevic M: Is perioperative chemotherapy useful for solitary, metachronous, colorectal liver metastases? Ann Surg 2010;252:774–787.PubMedCrossRef Adam R, Bhangui P, Poston G, Mirza D, Nuzzo G, Barroso E, Ijzermans J, Hubert C, Ruers T, Capussotti L, Ouellet JF, Laurent C, Cugat E, Colombo PE, Milicevic M: Is perioperative chemotherapy useful for solitary, metachronous, colorectal liver metastases? Ann Surg 2010;252:774–787.PubMedCrossRef
10.
go back to reference Lubezky N, Metser U, Geva R, Nakache R, Shmueli E, Klausner JM, Even-Sapir E, Figer A, Ben-Haim M: The role and limitations of 18-fluoro-2-deoxy-d-glucose positron emission tomography (fdg-pet) scan and computerized tomography (ct) in restaging patients with hepatic colorectal metastases following neoadjuvant chemotherapy: Comparison with operative and pathological findings. J Gastrointest Surg 2007;11:472–478.PubMedCrossRef Lubezky N, Metser U, Geva R, Nakache R, Shmueli E, Klausner JM, Even-Sapir E, Figer A, Ben-Haim M: The role and limitations of 18-fluoro-2-deoxy-d-glucose positron emission tomography (fdg-pet) scan and computerized tomography (ct) in restaging patients with hepatic colorectal metastases following neoadjuvant chemotherapy: Comparison with operative and pathological findings. J Gastrointest Surg 2007;11:472–478.PubMedCrossRef
11.
go back to reference Angliviel B, Benoist S, Penna C, El Hajjam M, Chagnon S, Julie C, Beauchet A, Rougier P, Nordlinger B: Impact of chemotherapy on the accuracy of computed tomography scan for the evaluation of colorectal liver metastases. Ann Surg Oncol 2009;16:1247–1253.PubMedCrossRef Angliviel B, Benoist S, Penna C, El Hajjam M, Chagnon S, Julie C, Beauchet A, Rougier P, Nordlinger B: Impact of chemotherapy on the accuracy of computed tomography scan for the evaluation of colorectal liver metastases. Ann Surg Oncol 2009;16:1247–1253.PubMedCrossRef
12.
go back to reference Schmidt J, Strotzer M, Fraunhofer S, Boedeker H, Zirngibl H: Intraoperative ultrasonography versus helical computed tomography and computed tomography with arterioportography in diagnosing colorectal liver metastases: Lesion-by-lesion analysis. World J Surg 2000;24:43–47; discussion 48.PubMedCrossRef Schmidt J, Strotzer M, Fraunhofer S, Boedeker H, Zirngibl H: Intraoperative ultrasonography versus helical computed tomography and computed tomography with arterioportography in diagnosing colorectal liver metastases: Lesion-by-lesion analysis. World J Surg 2000;24:43–47; discussion 48.PubMedCrossRef
13.
go back to reference Zacherl J, Scheuba C, Imhof M, Zacherl M, Langle F, Pokieser P, Wrba F, Wenzl E, Muhlbacher F, Jakesz R, Steininger R: Current value of intraoperative sonography during surgery for hepatic neoplasms. World J Surg 2002;26:550–554.PubMedCrossRef Zacherl J, Scheuba C, Imhof M, Zacherl M, Langle F, Pokieser P, Wrba F, Wenzl E, Muhlbacher F, Jakesz R, Steininger R: Current value of intraoperative sonography during surgery for hepatic neoplasms. World J Surg 2002;26:550–554.PubMedCrossRef
14.
go back to reference Leen E, Ceccotti P, Moug SJ, Glen P, MacQuarrie J, Angerson WJ, Albrecht T, Hohmann J, Oldenburg A, Ritz JP, Horgan PG: Potential value of contrast-enhanced intraoperative ultrasonography during partial hepatectomy for metastases: An essential investigation before resection? Ann Surg 2006;243:236–240.PubMedCrossRef Leen E, Ceccotti P, Moug SJ, Glen P, MacQuarrie J, Angerson WJ, Albrecht T, Hohmann J, Oldenburg A, Ritz JP, Horgan PG: Potential value of contrast-enhanced intraoperative ultrasonography during partial hepatectomy for metastases: An essential investigation before resection? Ann Surg 2006;243:236–240.PubMedCrossRef
15.
go back to reference Torzilli G, Botea F, Procopio F, Donadon M, Balzarini L, Lutman F, Calliada F, Montorsi M: Use of contrast-enhanced intraoperative ultrasonography during liver surgery for colorectal cancer liver metastases—its impact on operative outcome. Analysis of a prospective cohort study. EJC Suppl 2008;6:16–23. Torzilli G, Botea F, Procopio F, Donadon M, Balzarini L, Lutman F, Calliada F, Montorsi M: Use of contrast-enhanced intraoperative ultrasonography during liver surgery for colorectal cancer liver metastases—its impact on operative outcome. Analysis of a prospective cohort study. EJC Suppl 2008;6:16–23.
16.
go back to reference Shah AJ, Callaway M, Thomas MG, Finch-Jones MD: Contrast-enhanced intraoperative ultrasound improves detection of liver metastases during surgery for primary colorectal cancer. HPB (Oxford) 2010;12:181–187.CrossRef Shah AJ, Callaway M, Thomas MG, Finch-Jones MD: Contrast-enhanced intraoperative ultrasound improves detection of liver metastases during surgery for primary colorectal cancer. HPB (Oxford) 2010;12:181–187.CrossRef
17.
go back to reference Pang YY: The Brisbane 2000 terminology of liver anatomy and resections. HPB 2000; 2:333–39. HPB (Oxford) 2002;4:99; author reply 99–100. Pang YY: The Brisbane 2000 terminology of liver anatomy and resections. HPB 2000; 2:333–39. HPB (Oxford) 2002;4:99; author reply 99–100.
18.
go back to reference DeLeve LD, Shulman HM, McDonald GB: Toxic injury to hepatic sinusoids: Sinusoidal obstruction syndrome (veno-occlusive disease). Semin Liver Dis 2002;22:27–42.PubMedCrossRef DeLeve LD, Shulman HM, McDonald GB: Toxic injury to hepatic sinusoids: Sinusoidal obstruction syndrome (veno-occlusive disease). Semin Liver Dis 2002;22:27–42.PubMedCrossRef
19.
go back to reference Rubbia-Brandt L, Audard V, Sartoretti P, Roth AD, Brezault C, Le Charpentier M, Dousset B, Morel P, Soubrane O, Chaussade S, Mentha G, Terris B: Severe hepatic sinusoidal obstruction associated with oxaliplatin-based chemotherapy in patients with metastatic colorectal cancer. Ann Oncol 2004;15:460–466.PubMedCrossRef Rubbia-Brandt L, Audard V, Sartoretti P, Roth AD, Brezault C, Le Charpentier M, Dousset B, Morel P, Soubrane O, Chaussade S, Mentha G, Terris B: Severe hepatic sinusoidal obstruction associated with oxaliplatin-based chemotherapy in patients with metastatic colorectal cancer. Ann Oncol 2004;15:460–466.PubMedCrossRef
20.
go back to reference Zorzi D, Laurent A, Pawlik TM, Lauwers GY, Vauthey JN, Abdalla EK: Chemotherapy-associated hepatotoxicity and surgery for colorectal liver metastases. Br J Surg 2007;94:274–286.PubMedCrossRef Zorzi D, Laurent A, Pawlik TM, Lauwers GY, Vauthey JN, Abdalla EK: Chemotherapy-associated hepatotoxicity and surgery for colorectal liver metastases. Br J Surg 2007;94:274–286.PubMedCrossRef
21.
go back to reference Kulemann V, Schima W, Tamandl D, Kaczirek K, Gruenberger T, Wrba F, Weber M, Ba-Ssalamah A: Preoperative detection of colorectal liver metastases in fatty liver: Mdct or mri? Eur J Radiol 2011;79:e1–6.PubMedCrossRef Kulemann V, Schima W, Tamandl D, Kaczirek K, Gruenberger T, Wrba F, Weber M, Ba-Ssalamah A: Preoperative detection of colorectal liver metastases in fatty liver: Mdct or mri? Eur J Radiol 2011;79:e1–6.PubMedCrossRef
22.
go back to reference van Kessel CS, van Leeuwen MS, van den Bosch MA, Borel Rinkes IH, Mali WP, Westers P, van Hillegersberg R: Accuracy of multislice liver ct and mri for preoperative assessment of colorectal liver metastases after neoadjuvant chemotherapy. Dig Surg 2011;28:36–43.PubMedCrossRef van Kessel CS, van Leeuwen MS, van den Bosch MA, Borel Rinkes IH, Mali WP, Westers P, van Hillegersberg R: Accuracy of multislice liver ct and mri for preoperative assessment of colorectal liver metastases after neoadjuvant chemotherapy. Dig Surg 2011;28:36–43.PubMedCrossRef
23.
go back to reference Akhurst T, Kates TJ, Mazumdar M, Yeung H, Riedel ER, Burt BM, Blumgart L, Jarnagin W, Larson SM, Fong Y: Recent chemotherapy reduces the sensitivity of [18f]fluorodeoxyglucose positron emission tomography in the detection of colorectal metastases. J Clin Oncol 2005;23:8713–8716.PubMedCrossRef Akhurst T, Kates TJ, Mazumdar M, Yeung H, Riedel ER, Burt BM, Blumgart L, Jarnagin W, Larson SM, Fong Y: Recent chemotherapy reduces the sensitivity of [18f]fluorodeoxyglucose positron emission tomography in the detection of colorectal metastases. J Clin Oncol 2005;23:8713–8716.PubMedCrossRef
24.
go back to reference van Kessel CS, Buckens CF, van den Bosch MA, van Leeuwen MS, van Hillegersberg R, Verkooijen HM: Preoperative imaging of colorectal liver metastases after neoadjuvant chemotherapy: a meta-analysis. Ann Surg Oncol 2012;19:2805–2813 van Kessel CS, Buckens CF, van den Bosch MA, van Leeuwen MS, van Hillegersberg R, Verkooijen HM: Preoperative imaging of colorectal liver metastases after neoadjuvant chemotherapy: a meta-analysis. Ann Surg Oncol 2012;19:2805–2813
25.
go back to reference Fioole B, de Haas RJ, Wicherts DA, Elias SG, Scheffers JM, van Hillegersberg R, van Leeuwen MS, Borel Rinkes IH: Additional value of contrast enhanced intraoperative ultrasound for colorectal liver metastases. Eur J Radiol 2008;67:169–176.PubMedCrossRef Fioole B, de Haas RJ, Wicherts DA, Elias SG, Scheffers JM, van Hillegersberg R, van Leeuwen MS, Borel Rinkes IH: Additional value of contrast enhanced intraoperative ultrasound for colorectal liver metastases. Eur J Radiol 2008;67:169–176.PubMedCrossRef
26.
go back to reference Benoist M: The michel benoist and robert mulholland yearly european spine journal review: A survey of the “Medical” Articles in the european spine journal, 2005. Eur Spine J 2006;15:2–7.PubMedCrossRef Benoist M: The michel benoist and robert mulholland yearly european spine journal review: A survey of the “Medical” Articles in the european spine journal, 2005. Eur Spine J 2006;15:2–7.PubMedCrossRef
27.
go back to reference van Vledder MG, de Jong MC, Pawlik TM, Schulick RD, Diaz LA, Choti MA: Disappearing colorectal liver metastases after chemotherapy: Should we be concerned? J Gastrointest Surg 2010;14:1691–1700.PubMedCrossRef van Vledder MG, de Jong MC, Pawlik TM, Schulick RD, Diaz LA, Choti MA: Disappearing colorectal liver metastases after chemotherapy: Should we be concerned? J Gastrointest Surg 2010;14:1691–1700.PubMedCrossRef
28.
go back to reference Ferrero A, Langella S, Russolillo N, Vigano L, Lo Tesoriere R, Capussotti L: Intraoperative detection of disappearing colorectal liver metastases as a predictor of residual disease. J Gastrointest Surg 2012;16:806–814.PubMedCrossRef Ferrero A, Langella S, Russolillo N, Vigano L, Lo Tesoriere R, Capussotti L: Intraoperative detection of disappearing colorectal liver metastases as a predictor of residual disease. J Gastrointest Surg 2012;16:806–814.PubMedCrossRef
29.
go back to reference van Vledder MG, Pawlik TM, Munireddy S, Hamper U, de Jong MC, Choti MA: Factors determining the sensitivity of intraoperative ultrasonography in detecting colorectal liver metastases in the modern era. Ann Surg Oncol 2010;17:2756–2763.PubMedCrossRef van Vledder MG, Pawlik TM, Munireddy S, Hamper U, de Jong MC, Choti MA: Factors determining the sensitivity of intraoperative ultrasonography in detecting colorectal liver metastases in the modern era. Ann Surg Oncol 2010;17:2756–2763.PubMedCrossRef
30.
go back to reference van Vledder MG, Torbenson MS, Pawlik TM, Boctor EM, Hamper UM, Olino K, Choti MA: The effect of steatosis on echogenicity of colorectal liver metastases on intraoperative ultrasonography. Arch Surg 2010;145:661–667.PubMedCrossRef van Vledder MG, Torbenson MS, Pawlik TM, Boctor EM, Hamper UM, Olino K, Choti MA: The effect of steatosis on echogenicity of colorectal liver metastases on intraoperative ultrasonography. Arch Surg 2010;145:661–667.PubMedCrossRef
Metadata
Title
Usefulness of Contrast-Enhanced Intraoperative Ultrasonography (CE-IOUS) in Patients with Colorectal Liver Metastases after Preoperative Chemotherapy
Authors
Andrea Ruzzenente
Simone Conci
Calogero Iacono
Alessandro Valdegamberi
Tommaso Campagnaro
Francesca Bertuzzo
Fabio Bagante
Michela De Angelis
Alfredo Guglielmi
Publication date
01-02-2013
Publisher
Springer-Verlag
Published in
Journal of Gastrointestinal Surgery / Issue 2/2013
Print ISSN: 1091-255X
Electronic ISSN: 1873-4626
DOI
https://doi.org/10.1007/s11605-012-2043-y

Other articles of this Issue 2/2013

Journal of Gastrointestinal Surgery 2/2013 Go to the issue